• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership

Share:

January 18, 2021

CareMetx (or the “Company”), a leading technology-enabled hub services company improving patient access to specialty medications, General Atlantic, a global growth equity firm, and The Vistria Group, a Chicago-based private investment firm, today announced a strategic partnership to further accelerate the Company’s growth. With the transaction, General Atlantic will become the majority owner of CareMetx. The Vistria Group, existing majority shareholder in CareMetx since 2017, will maintain a significant position in the Company by reinvesting through Vistria Fund III, LP. Additionally, Marty Nesbitt, Co-CEO of The Vistria Group, will serve as the Chairman of the Company.

Co-founded in 2011 by Bob Dresing and Mark Hansan, hub services pioneers, CareMetx is leading the transformation of the industry from traditional call center services to a “Digital Hub” which integrates the Company’s proprietary technology platform with award-winning patient and provider support. CareMetx works on behalf of pharmaceutical and biotechnology companies to help patients and providers navigate reimbursement complexities and will continue to launch new products intended to lower the cost burden for patients on high-cost therapies.

Mark Hansan, President and CEO of CareMetx, said, “With patients continuing to face obstacles, we are excited to have the combined capabilities of General Atlantic and Vistria behind our efforts to scale our platform, invest in our team and bring new capabilities to our clients.”

“CareMetx is a disruptor in pharma commercialization services, differentiated by its focus on leveraging technology and grounded in its commitment to helping patients,” commented Justin Sunshine, Managing Director at General Atlantic. “CareMetx plays a critical role to ensure specialty therapeutics effectively reach the patients who need them, and we look forward to working with Mark and the CareMetx team to further accelerate the Company’s growth.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Over the last three years of our partnership, CareMetx has demonstrated its commitment to rethinking and reinventing traditional approaches to hub services,” continued Jon Maschmeyer, Partner at The Vistria Group. “We are proud to continue supporting CareMetx’s growth and welcome the new partnership with General Atlantic.”

“We are honored Vistria has decided to reinvest in CareMetx,” Hansan added. “They have been an outstanding partner that backed two important acquisitions and accelerated our development of new products and services. Now with General Atlantic as a partner, we are confident their years of investment across the healthcare ecosystem will help scale our delivery of real-time transaction processing and services to physician practices struggling to overcome barriers for patients.”

Terms of the deal were not disclosed. The Company was advised by Baird and North Point Advisors.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Verana Health Acquires PYA Analytics; Announces $100 Million Financing Round Led by GVVerana Health Acquires PYA Analytics; Announces $100 Million Financing Round Led by GV
  • Best Buy Health Now Offers Lively Health & Safety Services On Apple Watch For First TimeBest Buy Health Now Offers Lively Health & Safety Services On Apple Watch For First Time
  • Ankylosing Spondylitis Pipeline Market Report 2021Ankylosing Spondylitis Pipeline Market Report 2021
  • Investors Simmer on Hims & Hers Despite Strong Revenue Growth in 2020Investors Simmer on Hims & Hers Despite Strong Revenue Growth in 2020
  • Aveo Oncology Stock Spikes on Rumors of AstraZeneca AcquisitionAveo Oncology Stock Spikes on Rumors of AstraZeneca Acquisition
  • Cardiac Success Secures $5.2M for Transcatheter Ventricular Repair Device for Heart Failure PatientsCardiac Success Secures $5.2M for Transcatheter Ventricular Repair Device for Heart Failure Patients
  • Health Catalyst Announces Agreement to Acquire Vitalware, a Revenue Workflow Optimization and Analytics SaaS Technology SolutionHealth Catalyst Announces Agreement to Acquire Vitalware, a Revenue Workflow Optimization and Analytics SaaS Technology Solution
  • Mayo Clinic to Collaborate with Viome on AI-Driven Personalized Nutritional Strategies to Help Understand Sleep and ObesityMayo Clinic to Collaborate with Viome on AI-Driven Personalized Nutritional Strategies to Help Understand Sleep and Obesity

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications